| Jeffrey Lewis Hinson, DO | |
|
601 John St, Kalamazoo, MI 49007 | |
| (269) 341-7654 | |
| Not Available |
| Full Name | Jeffrey Lewis Hinson |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 601 John St, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518175728 | NPI | - | NPPES |
| 1518175728 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | R1174 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Hospital, St Joseph | St joseph, MI | Hospital |
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patholgy Services Of Kalamazoo Pc | 0143123034 | 15 |
| Southwest Michigan Pathology Services, Pc | 5496009433 | 11 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
| Entity Name | Patholgy Services Of Kalamazoo Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548243595 PECOS PAC ID: 0143123034 Enrollment ID: O20040128001118 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013089820 PECOS PAC ID: 0244148633 Enrollment ID: O20040804000437 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
| Entity Name | Diagnostic Pathology Services Of Southwest Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912241597 PECOS PAC ID: 1456598473 Enrollment ID: O20130513000074 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
| Entity Name | Southwest Michigan Pathology Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467944181 PECOS PAC ID: 5496009433 Enrollment ID: O20181112000155 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Lewis Hinson, DO 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Jeffrey Lewis Hinson, DO 601 John St, Kalamazoo, MI 49007 Ph: (269) 341-7654 |
News Archive
A new computational method developed by researchers at the New York Genome Center allows scientists to identify rare gene mutations in cancer cells with greater accuracy and sensitivity than currently available approaches.
In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01).
An autism study by Yale School of Medicine researchers using functional magnetic resonance imaging (fMRI) has identified a pattern of brain activity that may characterize the genetic vulnerability to developing autism spectrum disorder (ASD). Published today in the early edition of Proceedings of the National Academy of Sciences, the study could eventually lead to earlier and more accurate autism diagnosis.
The Association of Academic Health Centers has developed wherehealthbegins.org, an online toolkit of best practices and resources for academic health centers and their community partners to use in addressing the broad range of non-medical issues that impact health and well-being.
Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.
› Verified 8 days ago
Dr. Albert D Mason, MD Pathology Medicare: Medicare Enrolled Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Kevin M. Herzog, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. Nigel H. Bramwell, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Dr. William T Leeburg, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
William J Walter, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 | |
Dr. William P Walker, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 601 John St, Kalamazoo, MI 49007 Phone: 269-341-7654 | |
Steven P Soper, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-7000 |